Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730309 · ClinicalTrials.gov registry record · NA
Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
A NA study of Left Ventricular Hypertrophy, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05730309 is a NA study of Left Ventricular Hypertrophy that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, roughly in line with the 189-participant average among 7 other Left Ventricular Hypertrophy trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05730309, a NA study of Left Ventricular Hypertrophy, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-month outpatient follow-up and treatment rates for ED patients with newly diagnosed LVH by POCUS. Additionally, investigators will create a database of annotated clips for future development of a machine learning algorithm for LVH detection on POCUS.
Conditions Studied
Interventions
- BEHAVIORAL Customized discharge and expedited referral instructions
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-10-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05730309
The ClinicalTrials.gov registry entry for NCT05730309 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 189-participant average among 7 other Left Ventricular Hypertrophy trials with a reported enrollment target. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Left Ventricular Hypertrophy appearing as the primary indexed condition, and to 1 intervention - of which Customized discharge and expedited referral instructions is the first listed.
NCT05730309 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05730309 about?
NCT05730309 is a clinical study titled "Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy". The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-mont...
What is the current status of trial NCT05730309?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-10-15. Estimated completion is 2025-12.
What conditions does trial NCT05730309 study?
This clinical trial studies the following conditions: Left Ventricular Hypertrophy.
What interventions are being tested in trial NCT05730309?
The interventions under investigation include: Customized discharge and expedited referral instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05730309?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05730309 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Ventricular Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
Sodium Lowering Vascular Effects Trial
RECRUITING · NA
-
US Benchmarking Clinical Study
RECRUITING
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
RECRUITING · Phase 4
-
Diffusion MRI in Heart Failure
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.